Member Info for Sagetrade

Care to amend please?!

No assurances that this is us...I don’t think it is frankly...

Looking through your posting history, this is actually one of the most informative ones...... which says a lot.....

"A first pilot batch could possibly be available later this month to begin the clinical study."

Think this was missed by many....unfortunately seems we are still some way away with the LFT, and clearly having some difficulties with the tech transfer.....(as emphasised by the fact this mornings RNS stated that process was still ongoing).

Re 2 tests - Unless I’m missing something, ELISA = BAMS no?

No, I entirely agree the market is and will be there for the foreseeable - just a frustrating delay and no more than that....full confidence that the test works, will be best in class etc, was just surprised at the validation admission.....

Nothing sold here - check my posting history.

Simply disappointed that timeline seems to have slipped again given the validation admission - if just poorly worded than company needs to give clarification.

“Avacta aims to begin clinical validation of the test as soon as possible”.......

Somewhat bemused by this....how has this process not started?

On that note, I shall bid you farewell and filtered.

Pick your pants up on your way out, absolute ignorance.

Brilliant... so I’ve told you that private businesses with micro EBITDA can attract multiples of 6x + and you think we should discount this multiple to value an AIM pharma? This is brilliant.

1. So potential, growth opportunities and pipeline shouldn’t be built into earnings multiples? You’re really writing your own M&A rule book here aren’t you.
2. Just confirming you think 1x likely (in your head) LFT profits (unadjusted) is a “reasonable” valuation for Avacta?

So you’d value it at circa 4-6x unadjusted profit?!

I work in Corporate Finance and we sell private co’s with EBITDA of <£500k for 6x earnings, let alone an AIM listed pharma that has the potential to change both the covid and cancer landscape for the foreseeable.

You literally could not be more clueless re valuation. Just shut up!

Put your spade away mate.....

Regardless of the other utter tripe you post, you’ve really trumped yourself tonight. You clearly don’t have the first idea of what goes into company valuations and earnings multiples.

You are one sad ****er man....

Are you also seriously suggesting that a UK Pharma (Avacta) should be valued at 1x unadjusted EBITDA for one of its product lines! Absolutely comical ??

You’re right - most on here are LTH’s not interested in trading (me included).

Good luck to you.

F*** off you incoherent mug. I'm all for discussion and am frustrated (but understanding) of the delay in news flow, but at least have the decency to make a coherent argument. You're now just resorting to blatant de ramping nonsense.

https://twitter.com/davball15/status/1298233824887922688

Another cryptic AVCT tweet now deleted....

Brilliant...you quite literally said "Currently this is a slow burner however when the LFT is out the way and decent RNS out for Covid watch just watch this sky rocket so quickly, I think it will get to £20 - £30 easily."

Enjoy your day, let's keep the playground nonsense off here.

"Currently this is a slow burner however when the LFT is out the way and decent RNS out for Covid watch just watch this sky rocket so quickly, I think it will get to £20 - £30 easily."

And I'm the one smoking something? Keep the pie in the sky nonsense to yourself.